Description

Putting an End to Transplantation? Translating the Promise of Stem Cell Therapy into Practice
Brenda Ogle, PhD

(147) Impella RP Post Approval Study: First Multi-Center, Prospective Post Market Approval Results for the Impella RP in Patients with Right Ventriculoar Failure
Mark Anderson, MD

Interactive Discussant
Martin Strueber, MD

Metabolomics: New Tools to Understand Rejection
Brendan Keating, PhD

Speaker(s):

• Brenda Ogle, PhD, University of Minnesota
• Mark Anderson, MD, Einstein Healthcare Network
• Martin Strueber, MD, Beth Israel Medical Center, Newark, NJ, United States
• Dorry Segev, MD, PhD, Johns Hopkins School of Medicine
• Sommer Gentry, PhD, United States Naval Academy
• Sean Agbor-Enoh, MD, PhD, Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, MD, United States
• Erik Verschuuren, MD, PhD, University Medical Center, Groningen, Netherlands
• Brendan Keating, PhD, Hospital of the University of Pennsylvania